Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience

about

Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience

Item

http://www.wikidata.org/entity/Q28468387

description

2017 nî lūn-bûn

@nan

2017 թուականին հրատարակուած գիտական յօդուած

@hyw

2017 թվականին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience

@ast

Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience

@en

Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience

@nl

type

Item

label

Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience

@ast

Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience

@en

Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience

@nl

prefLabel

Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience

@ast

Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience

@en

Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience

@nl

P1476

Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience

@en

P2093

Alexander J Thompson

http://www.w3.org/2001/XMLSchema#string

Barbara Demediuk

http://www.w3.org/2001/XMLSchema#string

David M Iser

http://www.w3.org/2001/XMLSchema#string

Gideon Shaw

http://www.w3.org/2001/XMLSchema#string

Grace C Lovett

http://www.w3.org/2001/XMLSchema#string

Jacinta A Holmes

http://www.w3.org/2001/XMLSchema#string

Paul V Desmond

http://www.w3.org/2001/XMLSchema#string

Robert Chen

http://www.w3.org/2001/XMLSchema#string

Sally J Bell

http://www.w3.org/2001/XMLSchema#string

Tin Nguyen

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of tenofovir disoproxil fumarate in Asian-Americans with chronic hepatitis B in community settings

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

Chronic hepatitis B: update 2009

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular carcinoma.

Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load.

Continuous antiretroviral therapy decreases bone mineral density.

Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4254/WJH.V9.I1.48

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28105258

http://www.w3.org/2001/XMLSchema#string

P932

5220271

http://www.w3.org/2001/XMLSchema#string